Feed excerpt — reported by Science Daily
Blockbuster weight loss drugs like Ozempic and Mounjaro may do more than help people shed pounds, with growing evidence suggesting they could also influence brain health. Although studies have linked GLP-1 medications to a lower risk of dementia, major trials found that semaglutide did not slow Alzheimer's disease. Scientists suspect these drugs may be more effective at preserving memory and thinking abilities in people with obesity or diabetes, especially before cognitive problems appear.
MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at Science Daily →